Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 2Phase 3 2Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Osteoporosis 4Prostatic Neoplasms 3Breast Neoplasms 3Vitamin D Deficiency 2Polycystic Ovary Syndrome 2Neoplasms 2Cardiovascular Diseases 2Vitamin D3 1Neuroma 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Breast Cancer and Large Operable Breast Cancer 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Insulin Resistance 1Fractures, Bone 1Colorectal Adenocarcinoma 1

Interventions

Metformin 21Letrozole 11Clomiphene 7dapagliflozin 4Contraceptives, Oral 4Chorionic Gonadotropin 4cetrorelix 3Liraglutide 3Inositol 3follitropin beta 2follitropin alfa 2drospirenone and ethinyl estradiol combination 2Musculoskeletal Manipulations 2Glycoprotein Hormones, alpha Subunit 2DLBS3233 2Cholecalciferol 2semaglutide 1saxagliptin 1lime 1follicle stimulating hormone, human, with HCG C-terminal peptide 1drospirenone 1cinnulin PF 1Urofollitropin 1Triptorelin Pamoate 1Treatment Expectations 1Thioctic Acid 1Tamoxifen 1Tablets 1Sugars 1Sperm Injections, Intracytoplasmic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Polycystic Ovary Syndrome × Cholecalciferol × Clear all
NCT03792984 2019-06-06

The Effect of Calcium and Vitamin D Supplements on Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Patients

Damascus University

Phase 3 Completed
40 enrolled

Polycystic Ovary Syndrome, Vitamin D Deficiency

NCT02328404 2016-08-04

The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)

Hayat Pharmaceutical Co. PLC

Phase 3 Completed
60 enrolled 37 charts

Insulin Resistance, Polycystic Ovary Syndrome, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡